Page last updated: 2024-10-22

amodiaquine and Parkinson Disease

amodiaquine has been researched along with Parkinson Disease in 1 studies

Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, CH1
Han, BS1
Moon, J1
Kim, DJ1
Shin, J1
Rajan, S1
Nguyen, QT1
Sohn, M1
Kim, WG1
Han, M1
Jeong, I1
Kim, KS2
Lee, EH1
Tu, Y1
Naffin-Olivos, JL1
Park, CH1
Ringe, D1
Yoon, HS1
Petsko, GA1

Other Studies

1 other study available for amodiaquine and Parkinson Disease

ArticleYear
Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Jul-14, Volume: 112, Issue:28

    Topics: Amodiaquine; Animals; Behavior, Animal; Chloroquine; Disease Models, Animal; Ligands; Neurogenesis;

2015